Abstract
Background Severe paresis of the contralesional upper extremity is one of the most common and debilitating post-stroke impairments. The need for cost-effective high-intensity training is driving the development of new technologies, which can complement and extent conventional therapies. Apart from established methods using robotic devices, immersive virtual reality (iVR) systems hold promise to provide cost-efficient high-intensity arm training.
Objective We investigated whether iVR-based arm training yields at least equivalent effects on upper extremity function as compared to a robot-assisted training in stroke patients with severe arm paresis.
Methods 52 stroke patients with severe arm paresis received a total of ten daily group therapy sessions over a period of three weeks, which consisted of 20 minutes of conventional therapy and 20 minutes of either robot-assisted (ARMEOSpring®) or iVR-based (CUREO®) arm training. Changes in upper extremity function was assessed using the Action Research Arm Test (ARAT) and user acceptance was measured with the User Experience Questionnaire (UEQ).
Results iVR-based training was not inferior to robot-assisted training. We found that 84% of patients treated with iVR and 50% of patients treated with robot-assisted arm training showed a clinically relevant improvement of upper extremity function. This difference could neither be attributed to differences between the groups regarding age, gender, duration after stroke, affected body side or ARAT scores at baseline, nor to differences in the total amount of therapy provided.
Conclusion The present study results show that iVR-based arm training seems to be a promising addition to conventional therapy. Potential mechanisms by which iVR unfolds its effects are discussed.
Registry number DRKS00032489
Competing Interest Statement
BS is now employed at Hocoma AG; no relationship existed at the time of the design or execution of this study. TSW is shareholder of Cureosity. TSW was neither involved in data acquisition nor in statistical analyses.
Clinical Trial
DRKS00032489
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in accordance with the Declaration of Helsinki and had been approved by the Ethics Committee of the Aerztekammer Nordrhein (serial number: 2020079). Prior to study enrolment, participants gave written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- ARAT
- Action Research Arm Test
- BBT
- Box and Block Test
- HMD
- head mounted display
- ICF
- International Classification of Functioning
- iVR
- immersive virtual reality
- UEQ
- User Experience Questionnaire
- VR
- virtual reality
